cysteine and carbobenzoxy-leucyl-leucyl-norvalinal

cysteine has been researched along with carbobenzoxy-leucyl-leucyl-norvalinal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ang, E; Chai, T; Pavlos, NJ; Qi, M; Ratajczak, T; Rea, SL; Walsh, JP; Xu, J; Zheng, MH1

Other Studies

1 other study(ies) available for cysteine and carbobenzoxy-leucyl-leucyl-norvalinal

ArticleYear
Proteasome inhibitors impair RANKL-induced NF-kappaB activity in osteoclast-like cells via disruption of p62, TRAF6, CYLD, and IkappaBalpha signaling cascades.
    Journal of cellular physiology, 2009, Volume: 220, Issue:2

    Topics: Actins; Animals; Bone Resorption; Cell Line; Cysteine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Deubiquitinating Enzyme CYLD; Erythropoietin; Humans; I-kappa B Proteins; Leupeptins; Mice; Mice, Inbred C57BL; Microtubules; NF-kappa B; NF-KappaB Inhibitor alpha; Oligopeptides; Osteoclasts; Proteasome Endopeptidase Complex; Proteasome Inhibitors; RANK Ligand; Signal Transduction; Synaptotagmin I; TNF Receptor-Associated Factor 6; Transcription Factor TFIIH; Transcription Factors

2009